Skip to content
GenoLensGenoLens

MED11

Chr 17p13.2

mediator complex subunit 11

Aliases:
HSPC296, MGC88387
MANE:
ENST00000293777.6

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Early onset or syndromic epilepsy

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Severe microcephaly

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities

    0.64
  • neurodegenerative disease

    0.19
  • neurodevelopmental disorder

    0.18
  • bone remodeling disease

    0.15
  • MODY

    0.09
  • maturity-onset diabetes of the young type 3

    0.07
  • transient neonatal diabetes mellitus

    0.07
  • 3-hydroxy-3-methylglutaryl-CoA synthase deficiency

    0.06
  • diabetes mellitus, transient neonatal, 3

    0.05
  • glycogen storage disorder due to hepatic glycogen synthase deficiency

    0.05

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Mediator of RNA polymerase II transcription subunit 11

Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional pre-initiation complex with RNA polymerase II and the general transcription factors

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.